Diversity in Oncology fosters courageous conversations about strategies for the delivery of equitable high quality cancer care for all including clinical trials, so that this cross-stakeholder, cross-cultural initiative can take action to make the clinical trial enterprise more inclusive and responsive to populations that are currently underrepresented.

Who Should Attend

  • Local and national community organizations that focus on health equity
  • Patients and caregivers
  • Healthcare providers
  • Clinical trial teams and principal investigators
  • Schools of public health
  • Anyone interested in discussing health equity in clinical trials

attend-divonc